Despite steady demand for obesity medications, 49% of payers who do not currently cover GLP-1s for obesity would not do so at any price, a new
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor,…
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…
The Pharmaceutical Care Management Association released a new policy platform, which includes six | The Pharmaceutical Care…
Fewer than a third of people with commercial coverage say that their plans represent a "trusted partner" in their health,…
A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans…
More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the…
